Coverage: The Meridian legal market record (editorial).
MENA-region scope; no African country is named in the release coverage reviewed, so the African nexus is regional and flagged.
| Record ID | TX-AFR-2026-0025 |
|---|---|
| Record type | Commercial IP transaction |
| Transaction type | Trade mark licence, Exclusive licence, In-licensing |
| IP rights | trade mark, regulatory data |
| Status | Signed |
| Qualifying date | 2026-09-28 |
| Sector | Life sciences · Pharmaceuticals – consumer health |
| African markets | Multi-jurisdictional |
| Licensed territory | MENA region. |
| Disclosed value | Not disclosed in the sources reviewed. |
| Evidence | Primary source, single · 1 source(s) |
| Last verified | 2026-10-25 |
Parties
- Hikma Pharmaceuticals International Limited (United Kingdom): licensee
- Dr. Reddy's Laboratories SA (India): licensor
Key terms
- Interest: exclusive licence; Exclusivity: exclusive; Territorial scope: MENA region; Term: Multi-year (no term length stated)
Sources
- Hikma signs exclusive licensing and distribution agreement with Dr. Reddy's Laboratories for Nicotinell across MENA, Zawya (press release), 2026-09-28
Part of The Meridian’s Africa IP database. Counts, market breakdowns and rankings are derived from published records only; a record counts once. Corrections: submit evidence.


